0
0
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Product Insights

    $2,000 | January 2024
    Product Insights

    Lung Adenocarcinoma – Drugs In Development, 2023

    Global Markets Direct’s, ‘Lung Adenocarcinoma - Drugs In Development, 2023’, provides an overview of the Lung Adenocarcinoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lung Adenocarcinoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Atherosclerosis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Atherosclerosis - Drugs In Development, 2023’, provides an overview of the Atherosclerosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Atherosclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Arteriosclerosis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Arteriosclerosis - Drugs In Development, 2023’, provides an overview of the Arteriosclerosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Arteriosclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Company Profile

    $295 | February 2024
    Company Profile

    Helix OpCo LLC – Company Profile

    Helix OpCo LLC (Helix) a provider of genomic testing applications and services. The company through its genome discovery platform sequences, stores, and analyzes an individual's genetic data. It provides insights to the individuals that enable them to make decisions related to health, fitness, nutrition, family, and ancestry. Helix also helps people explore their genealogy and understand the risk of inherited diseases. Helix is headquartered in San Carlos, California, the US.

    Add to Basket
  • Company Profile

    $295 | February 2024
    Company Profile

    Penney OpCo LLC – Company Profile

    Penney OpCo LLC (JC Penney) operates a chain of department stores that offers a portfolio of private and national brands. It provides a range of apparel, home furnishings, accessories, footwear, handbags, jewelry, shoes, watches, beauty products, and bed and bath products. The company operates salons, optical centers, portrait studios, jewelry repair shops, custom decoration, and flower bouquet shops in its retail centers and offers gift cards. It sells products of various brands such as Liz Claiborne, Claiborne, Okie Dokie, Worthington,...

    Add to Basket
  • Thematic Analysis

    $995 | May 2023
    Thematic Analysis

    Genomics – Thematic Intelligence

    Genomics Market Thematic Report Overview Genomics refers to the study of an entire set of DNA within an organism. This includes researching their molecular components, structures, and functions of genes, and developing technologies that map and edit sequences of DNA. Direct-to-consumer genetic testing (DTC-GT) has been a rapidly expanding market that continues to generate substantial amounts of revenue and public interest. The rapid growth of the market has historically been accompanied by regulatory limitations on the extent of consumer health...

  • Company Profile

    $295 | January 2024
    Company Profile

    IB Opco Holding SL – Company Profile

    IB Opco Holding SL (Iberia), is a provider of scheduled passenger air transportation and air cargo services. Iberia also provides aircraft maintenance, airport handling, load control, flight operations, baggage assistance, flight dispatching, aircraft assistance, passenger, and cargo services. Its fleet of aircraft includes Airbus A350, Airbus A340, Airbus A330 200/300, Airbus A321, Airbus A320 and A320neo, Airbus A319, Airbus A320, CRJ-200, CRJ-900, CRJ-1000 and ATR-72-600. The company operates through the brands Iberia, Iberia Regional Airnostrum, and Iberia Express. The company...

    Add to Basket
  • Product Insights

    New
    $500 | April 2024
    Product Insights
    New

    Helix OpCo LLC Pipeline Insight and Competitive Landscape, 2023

    Empower your strategies with our Helix OpCo LLC Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Helix OpCo LLC (Helix) is a provider of genomic testing applications and services. The company through its genome discovery platform sequences, stores, and analyzes an individuals genetic data. It provides insights to the individuals that enable them to make decisions related to health, fitness, nutrition, family, and ancestry. Helix also helps people explore their genealogy and understand risk of...

  • Company Profile

    $295 | February 2024
    Company Profile

    Nextera Energy Partners LP – Company Profile

    Nextera Energy Partners LP (NEP), a subsidiary of NextEra Energy, Inc. (NEE) involves in acquisition and operation of contracted clean energy projects. It also owns interests in wind, natural gas pipeline assets and solar projects. The company through its partner NEP OpCo owns a portfolio of contracted renewable generation assets consisting of wind and solar projects including natural gas pipeline assets. NEP’s natural gas pipeline assets portfolio comprise NET Mexico, Eagle Ford and other. It caters services to power producers...

    Add to Basket
  • Analyst Opinions

    $995 | September 2022
    Analyst Opinions

    Advanced Genomics – Key Disruptive Forces to Transform Health and Wellness

    Advances in genomics have revolutionized approaches to healthcare and precision medicine. The major drivers of genomics include personalized medicine, customized genetic counseling, genetic predisposition identification, accurate disease diagnosis, disease prevention, and optimized treatments. Advances in genomics are significantly reducing the cost of genome sequencing. Genomic techniques not only help in understanding the nature of the virus to trace its potential origins but also aids in tracking disease outbreaks. The Advanced Genomics FutureTech Series report categorizes 30+ disruptive forces in genomics...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.